How does pfo cause stroke

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 17, 2026

Quick Answer: A patent foramen ovale (PFO) can cause stroke when a blood clot passes from the right to the left atrium of the heart, bypassing the lungs and traveling to the brain. This 'paradoxical embolism' accounts for up to 5-10% of cryptogenic strokes in young adults under age 55.

Key Facts

PFO is present in about 25% of the general population but only rarely causes complications.
Up to 50% of cryptogenic strokes in patients under 55 may be linked to PFO.
The risk of stroke in PFO patients increases 2- to 5-fold if a venous thrombosis is also present.
Closure of PFO reduces stroke recurrence by 44% compared to medical therapy alone, per 2017 NEJM studies.
PFO-related strokes are typically embolic, not hemorrhagic, and often occur without traditional vascular risk factors.

Overview

A patent foramen ovale (PFO) is a persistent opening between the heart’s upper chambers that fails to close after birth. While harmless in most people, it can become a pathway for blood clots to bypass the lungs and enter the arterial system, potentially leading to stroke.

This condition is especially significant in cases of cryptogenic stroke—strokes with no identifiable cause. In younger patients, PFO is a leading suspect when traditional risk factors like hypertension or atherosclerosis are absent.

Prevalence: Approximately 1 in 4 adults has a PFO, making it one of the most common cardiac anomalies.
Age factor: PFO-related strokes are most commonly diagnosed in adults under 55 years old, especially those without diabetes or smoking history.
Paradoxical embolism: A clot originating in the legs or pelvis can cross the PFO, enter the left atrium, and travel to the brain.
Diagnostic methods: Transesophageal echocardiography (TEE) is the gold standard, detecting PFO with 95% sensitivity when combined with bubble study.
Size matters: PFOs larger than 2 mm in diameter are more likely to be associated with stroke events.

How It Works

Understanding how a PFO leads to stroke requires knowledge of specific physiological mechanisms and anatomical vulnerabilities.

Right-to-left shunt: During sudden pressure increases (e.g., coughing, straining), blood can flow from the right to the left atrium through the PFO, bypassing pulmonary filtration.
Thrombus origin: Deep vein thromboses (DVTs) in the legs are the most common source of clots that cause paradoxical embolism via PFO.
Pulmonary filter bypass: Normally, lung capillaries trap clots; a PFO allows 10–20% of venous clots to escape filtration and reach systemic circulation.
Shunt volume: Patients with large right-to-left shunts on echocardiography have a 3.5 times higher stroke risk than those with small or no shunt.
Atrial septal aneurysm: When present with PFO, this condition increases stroke risk by 2.8-fold due to increased shunting.
Hypercoagulable states: Conditions like Factor V Leiden mutation can amplify clot formation, raising the likelihood of PFO-mediated stroke.

Comparison at a Glance

How PFO-related stroke compares to other stroke types:

Stroke Type	Common Age Group	Primary Cause	PFO Association	Recurrence Risk
Cryptogenic (PFO-linked)	Under 55	Paradoxical embolism	40–50%	0.5% per year with closure
Large vessel atherosclerosis	Over 65	Plaque rupture	5–10%	3–5% per year
Cardioembolic (e.g., AFib)	Over 70	Atrial clot formation	1–2%	6–8% per year
Small vessel disease	60–75	Hypertensive changes	1–3%	2–3% per year
Other embolic sources	Variable	Endocarditis, tumor	10–15%	4–6% per year

The data shows PFO-related strokes are distinct in their younger patient profile and lower recurrence rates when managed appropriately. Closure devices have significantly improved outcomes, especially in those with large shunts or prior embolic events.

Why It Matters

Recognizing PFO as a stroke mechanism transforms treatment options and preventive strategies, particularly in otherwise healthy individuals. Early diagnosis can prevent recurrent events through targeted interventions.

Secondary prevention: PFO closure reduces recurrent stroke risk by 44% compared to antiplatelet therapy alone.
Cost-effectiveness: Closure is cost-effective over 5 years for patients under 60 with no other stroke causes.
Guideline recognition: The 2021 AHA/ASA guidelines recommend closure for select patients with cryptogenic stroke and high-risk PFO features.
Travel risk: Long-haul flights increase DVT risk, making PFO screening relevant for frequent flyers with unexplained neurological symptoms.
Genetic links: Some families show inherited patterns of PFO and thrombophilia, suggesting a hereditary component.
Public awareness: Only 30% of adults know about PFO, highlighting a need for better education on hidden stroke risks.

As imaging and closure technologies improve, identifying and treating PFO becomes a critical tool in reducing stroke burden, especially in younger populations. Proactive screening and multidisciplinary care can significantly alter patient outcomes.